Der var en signifikant forskel i tolerancen over for fenylalaninindtaget via kosten i gruppen behandlet med sapropterindihydrochlorid sammenlignet ned placebogruppen.
There was a significant difference in dietary phenylalanine tolerance in the sapropterin treatment group as compared to the placebo group.